Okobilanz Biochem Limited Liabilty Partnership - Company Profile

It is a chemicals and materials limited liability partnership based in Mumbai, Maharashtra, India, established in 2011.
2011 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Okobilanz Biochem Limited Liabilty Partnership

Okobilanz Biochem Limited Liabilty Partnership, a active limited liability partnership, was established on 11 February 2011 in Mumbai, Maharashtra, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds LLPIN: AAA-3782. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Ajaykumar Gopalkrishna Pillai (Designated Partner), Trupti Yatin Desai (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at 106 Prospect Chambers, Dr. D. N. Road, Fort, Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAA-3782

  • Incorporation Date

    11 February 2011

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 15 Year, 11 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -27.15%
  • Profit Growth **** 146.07%
  • Ebitda **** 289.20%
  • Total Assets -18.23%
Company report

Okobilanz Biochem Limited Liabilty Partnership

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Okobilanz Biochem Limited Liabilty Partnership — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Okobilanz Biochem Limited Liabilty Partnership?
Current Designated Partners
Name Designation Appointment Date Status
Ajaykumar Gopalkrishna Pillai Designated Partner 11 Feb 2011 Current
Trupti Yatin Desai Designated Partner 11 Feb 2011 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Okobilanz BiochemLiabilty Partnership.

Okobilanz Biochem Limited Liabilty Partnership, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.15% decrease. The company also saw a substantial improvement in profitability, with a 146.07% increase in profit. The company's net worth witnessed no change by increase of 0%.

Okobilanz BiochemLiabilty Partnership revenue growth over time
Okobilanz BiochemLiabilty Partnership profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -27.15%
*******
*******
*******
*******
Revenue from Operations
*******
 -27.22%
*******
*******
*******
*******
Total Assets
*******
 -18.23%
*******
*******
*******
*******
Profit or Loss
*******
 146.07%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 289.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Okobilanz BiochemLiabilty Partnership?

Unlock access to Okobilanz BiochemLiabilty Partnership's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Okobilanz BiochemLiabilty Partnership?

Unlock and access historical data on people associated with Okobilanz BiochemLiabilty Partnership, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Okobilanz BiochemLiabilty Partnership, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Okobilanz BiochemLiabilty Partnership's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Okobilanz BiochemLiabilty Partnership
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Okobilanz Biochem Limited Liabilty Partnership last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    Progress on Okobilanz Biochem Limited Liabilty Partnership has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Ajaykumar Gopalkrishna Pillai was appointed as a Designated Partner was appointed as a Designated Partner on 11 Feb 2011 & has been associated with this company since 15 years 11 days . was completed.

  • Director Appointment

    The activity Trupti Yatin Desai was appointed as a Designated Partner was appointed as a Designated Partner on 11 Feb 2011 & has been associated with this company since 15 years 11 days . was completed.

  • LLP Incorporation

    The activity Okobilanz Biochem Limited Liabilty Partnership was registered on 11 Feb 2011 with Roc Mumbai & aged 15 years 11 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Okobilanz Biochem Limited Liabilty Partnership?

The LLPIN of Okobilanz Biochem Limited Liabilty Partnership is AAA-3782.

Where is Okobilanz Biochem Limited Liabilty Partnership headquartered?

Okobilanz Biochem Limited Liabilty Partnership is headquartered at 106 Prospect Chambers, Dr. D. N. Road, Fort, Mumbai, Maharashtra, 400001.

When was Okobilanz Biochem Limited Liabilty Partnership incorporated?

Okobilanz Biochem Limited Liabilty Partnership was incorporated on 11 February 2011.

Who are the current directors of Okobilanz Biochem Limited Liabilty Partnership?

The current directors of Okobilanz Biochem Limited Liabilty Partnership are

What is the primary industry of Okobilanz Biochem Limited Liabilty Partnership?

The primary industry of Okobilanz Biochem Limited Liabilty Partnership is Chemicals And Materials.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available